ABBEY STRAUSS: Open Payments
NPI 1124005913 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 28 payments from 7 companies in 2025. Trend: 2023 $2,251 · 2024 $2,379 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $376 |
| Teva Pharmaceuticals USA, Inc. | 9 | $367 |
| Neurocrine BioSciences, Inc. | 7 | $264 |
| Lilly USA, LLC | 1 | $90 |
| TMS NeuroHealth Centers Inc. | 2 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Alkermes, Inc. | 2 | $50 |
Products named: CAPLYTA, AUSTEDO XR, INGREZZA, KISUNLA, TMS NeuroHealth Centers Inc., TRINTELLIX, ARISTADA.
Industry payments across FL — which companies pay providers there.
